23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › TG THERAPEUTICS INC. › 2023-2024

TG THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 10Ballot items
  • 242Asset managers, any item
  • 1,971Fund votes
  • June 14, 2024Meeting date

Results at a glance

Meeting of June 14, 2024: 10 items on TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024: 7 passed (calculated) · 3 plurality election.

Dissent

Significant dissent: 6 directors (56.3%, 54.0%, 53.9%, 31.6%, 24.8%, 24.1% against); 1 say-on-pay vote (57.7% support).

Notable dissent: 1 other board item (33.0% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TG THERAPEUTICS INC.

These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TG THERAPEUTICS INC. — official shareholder meeting results, meeting held June 14, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Michael S. Weiss 57,264,472---- 18,849,95434,960,603 75%Passed (calculated)—
Elect Director: Laurence N. Charney 57,758,626---- 18,355,80034,960,603 76%Passed (calculated)—
Elect Director: Yann Echelard 35,052,596---- 41,061,83034,960,603 46.1%Plurality election—
Elect Director: Kenneth Hoberman 52,058,723---- 24,055,70334,960,603 68%Passed (calculated)—
Elect Director: Daniel Hume 35,036,823---- 41,077,60334,960,603 46.0%Plurality election—
Elect Director: Sagar Lonial, MD 33,299,870---- 42,814,55634,960,603 44%Plurality election—
2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 110,028,319657,578389,132 ---- 99.4%Passed (calculated)—
3. Advisory vote to approve the compensation of the Company's named executive officers 42,346,58131,019,0842,748,761 --34,960,603 58%Passed (calculated)—
4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000 73,780,22536,348,764946,040 ---- 67%Passed (calculated)—
5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit 66,744,1428,625,685744,599 --34,960,603 89%Passed (calculated)—

Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2024 — read the filing on EDGAR.

How asset managers voted at the TG THERAPEUTICS INC. 2023-2024 meeting

242 asset managers disclosed a vote on at least one TG THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Daniel Hume

Calculated outcomeDIRECTOR ELECTIONSPlurality election

Combines 3 wordings of this item as funds reported it.

46.0% Plurality election · of votes cast

FOR 46.0%WITHHELD
FOR: 35,036,823WITHHELD: 41,077,603

Prior year: 40.5% for (June 14, 2023 meeting) ▲ 5.6 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Daniel Hume

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 35,036,823 for, 41,077,603 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 46.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 4,638,977 for, 20,108,064 withheld, 126,293 abstained.

FORWITHHOLD
FOR: 4,638,977ABSTAIN: 126,293WITHHOLD: 20,108,064
Largest asset managers voting on “Election of Directors: Daniel Hume” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard3,066,3040 013,143,664Mixed
State Street1,7680 01,621,193Withhold
TIAA00 01,217,287Withhold
Charles Schwab00 01,148,610Withhold
Fidelity750,9860 0204,726Mixed
BlackRock00 0877,944Withhold
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable00 0374,322Withhold
Lincoln Financial00 0177,050Withhold
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC00 0127,185Withhold
SEI00 0110,717Withhold
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X00 063,047Withhold
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life00 047,089Withhold
JPMorgan00 46,9960Abstain
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO00 030,412Withhold
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Kenneth Hoberman

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%WITHHELD
FOR: 52,058,723WITHHELD: 24,055,703

Prior year: 58.6% for (June 14, 2023 meeting) ▲ 9.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Kenneth Hoberman

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 52,058,723 for, 24,055,703 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 19,671,625 for, 5,075,416 withheld, 126,293 abstained.

FORWITHHOLD
FOR: 19,671,625ABSTAIN: 126,293WITHHOLD: 5,075,416
Largest asset managers voting on “Election of Directors: Kenneth Hoberman” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,620,5980 02,363For
TIAA00 01,217,287Withhold
Charles Schwab00 01,148,610Withhold
Fidelity879,7900 075,922Mixed
BlackRock00 0877,944Withhold
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable00 0374,322Withhold
Lincoln Financial116,0000 061,050Mixed
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC00 0127,185Withhold
SEI00 0110,717Withhold
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X00 063,047Withhold
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life00 047,089Withhold
JPMorgan00 46,9960Abstain
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO00 030,412Withhold
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Laurence N. Charney

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

76% Majority: yes · of votes cast

FOR 76%WITHHELD
FOR: 57,758,626WITHHELD: 18,355,800

Prior year: 66.1% for (June 14, 2023 meeting) ▲ 9.8 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Laurence Charney

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 57,758,626 for, 18,355,800 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 21,075,399 for, 3,697,457 withheld, 100,478 abstained.

FORWITHHOLD
FOR: 21,075,399ABSTAIN: 100,478WITHHOLD: 3,697,457
Largest asset managers voting on “Election of Directors: Laurence Charney” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,620,5980 02,363For
TIAA00 01,217,287Withhold
Charles Schwab00 01,148,610Withhold
Fidelity953,5720 02,140For
BlackRock877,9440 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable213,4020 0160,920Mixed
Lincoln Financial116,0000 061,050Mixed
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC127,1850 00For
SEI00 0110,717Withhold
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X00 063,047Withhold
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life47,0890 00For
JPMorgan00 46,9960Abstain
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO30,4120 00For
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Michael S. Weiss

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD
FOR: 57,264,472WITHHELD: 18,849,954

Prior year: 75.8% for (June 14, 2023 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Michael S. Weiss

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 57,264,472 for, 18,849,954 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 20,683,032 for, 4,139,496 withheld, 50,806 abstained.

FORWITHHOLD
FOR: 20,683,032ABSTAIN: 50,806WITHHOLD: 4,139,496
Largest asset managers voting on “Election of Directors: Michael S. Weiss” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,7680 01,621,193Withhold
TIAA00 01,217,287Withhold
Charles Schwab1,148,6100 00For
Fidelity953,5720 02,140For
BlackRock877,9440 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable213,4020 0160,920Mixed
Lincoln Financial00 0177,050Withhold
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC127,1850 00For
SEI110,7170 00For
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X63,0470 00For
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life47,0890 00For
JPMorgan46,9960 00For
Voya00 045,536Withhold
MASTER INVESTMENT PORTFOLIO30,4120 00For
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Sagar Lonial, MD

Calculated outcomeDIRECTOR ELECTIONSPlurality election

Combines 3 wordings of this item as funds reported it.

44% Plurality election · of votes cast

FOR 44%WITHHELD
FOR: 33,299,870WITHHELD: 42,814,556

Prior year: 39.5% for (June 14, 2023 meeting) ▲ 4.2 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Sagar Lonial, MD

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 33,299,870 for, 42,814,556 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 44% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 3,971,258 for, 20,775,783 withheld, 126,293 abstained.

FORWITHHOLD
FOR: 3,971,258ABSTAIN: 126,293WITHHOLD: 20,775,783
Largest asset managers voting on “Election of Directors: Sagar Lonial, MD” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard3,066,3040 013,143,664Mixed
State Street1,7680 01,621,193Withhold
TIAA00 01,217,287Withhold
Charles Schwab00 01,148,610Withhold
Fidelity128,8040 0826,908Mixed
BlackRock00 0877,944Withhold
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable00 0374,322Withhold
Lincoln Financial00 0177,050Withhold
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC00 0127,185Withhold
SEI00 0110,717Withhold
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X00 063,047Withhold
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life00 047,089Withhold
JPMorgan00 46,9960Abstain
Voya00 045,536Withhold
MASTER INVESTMENT PORTFOLIO00 030,412Withhold
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

Elect Director: Yann Echelard

Calculated outcomeDIRECTOR ELECTIONSPlurality election

Combines 3 wordings of this item as funds reported it.

46.1% Plurality election · of votes cast

FOR 46.1%WITHHELD
FOR: 35,052,596WITHHELD: 41,061,830

Prior year: 40.4% for (June 14, 2023 meeting) ▲ 5.6 pts

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors: Yann Echelard

TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 35,052,596 for, 41,061,830 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 46.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 4,638,484 for, 20,108,557 withheld, 126,293 abstained.

FORWITHHOLD
FOR: 4,638,484ABSTAIN: 126,293WITHHOLD: 20,108,557
Largest asset managers voting on “Election of Directors: Yann Echelard” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard3,066,3040 013,143,664Mixed
State Street1,7680 01,621,193Withhold
TIAA00 01,217,287Withhold
Charles Schwab00 01,148,610Withhold
Fidelity750,9860 0204,726Mixed
BlackRock00 0877,944Withhold
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable00 0374,322Withhold
Lincoln Financial00 0177,050Withhold
Direxion Shares ETF Trust00 0175,509Withhold
First Trust00 0157,249Withhold
Goldman Sachs00 0145,974Withhold
QUANTITATIVE MASTER SERIES LLC00 0127,185Withhold
SEI00 0110,717Withhold
ProShares00 0101,760Withhold
AIG/SunAmerica00 072,333Withhold
Global X00 063,047Withhold
Guggenheim00 060,516Withhold
John Hancock00 50,7930Abstain
Pacific Life00 047,089Withhold
JPMorgan00 46,9960Abstain
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO00 030,412Withhold
New York Life28,4710 00For
T. Rowe Price00 027,853Withhold

Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).

The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the…

Calculated outcomeCAPITAL STRUCTUREPassed (calculated)

Combines 4 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%AGAINST
FOR: 73,780,225AGAINST: 36,348,764
Details: description as filed, official tally, votes by 58 asset managers

Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 175,000,000 TO 190,000,000.

TG THERAPEUTICS INC.’s own tally for this item (“4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000”): 73,780,225 for, 36,348,764 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 67% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 58 asset managers below reported 22,413,799 for, 2,463,299 against.

FOR
FOR: 22,413,799AGAINST: 2,463,299
Largest asset managers voting on “TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COM” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,620,5982,363 00For
TIAA1,217,2870 00For
Charles Schwab1,148,6100 00For
Fidelity879,79075,922 00Mixed
BlackRock0877,944 00Against
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable0374,322 00Against
Lincoln Financial116,00061,050 00Mixed
Direxion Shares ETF Trust0175,509 00Against
First Trust0157,249 00Against
Goldman Sachs145,9740 00For
QUANTITATIVE MASTER SERIES LLC0127,185 00Against
SEI110,7170 00For
ProShares0101,760 00Against
AIG/SunAmerica072,333 00Against
Global X63,0470 00For
Guggenheim060,516 00Against
John Hancock050,793 00Against
Pacific Life047,089 00Against
JPMorgan046,996 00Against
Voya045,536 00Against
MASTER INVESTMENT PORTFOLIO030,412 00Against
New York Life28,4710 00For
T. Rowe Price27,8530 00For

Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).

The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit

Calculated outcomeFund totals may overlapCOMPENSATIONPassed (calculated)

Combines 7 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 66,744,142AGAINST: 8,625,685
Details: description as filed, official tally, votes by 61 asset managers

Description as filed by funds: To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.

TG THERAPEUTICS INC.’s own tally for this item (“5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit”): 66,744,142 for, 8,625,685 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 56 asset managers voting on “To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,622,688273 00For
TIAA1,217,2870 00For
Charles Schwab1,148,6100 00For
Fidelity955,7120 00For
BlackRock877,9440 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable374,3220 00For
Lincoln Financial177,0500 00For
Direxion Shares ETF Trust175,5090 00For
First Trust157,2490 00For
Goldman Sachs145,9740 00For
QUANTITATIVE MASTER SERIES LLC127,1850 00For
SEI110,7170 00For
ProShares101,7600 00For
AIG/SunAmerica72,3330 00For
Global X63,0470 00For
Guggenheim60,5160 00For
John Hancock50,7930 00For
Pacific Life47,0890 00For
JPMorgan46,9960 00For
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO30,4120 00For
New York Life28,4710 00For
T. Rowe Price27,8530 00For

Fund voting reports, all 56 managers: 24,836,815 for, 22,899 against, 13,620 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 4 asset managers voting on “To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Duquesne Family Office LLC280,0000 00For
GRIMES & COMPANY, INC.6,1000 00For
Jackson Creek Investment Advisors LLC2,7640 00For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC1,0000 00For

Institutional-manager reports, all 4 managers: 289,864 for.

Advisory vote to approve the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 7 wordings of this item as funds reported it.

58% Majority: yes · of votes cast

FOR 58%AGAINST
FOR: 42,346,581AGAINST: 31,019,084

Prior year: 37.4% for (June 14, 2023 meeting) ▲ 20.3 pts

Details: description as filed, official tally, votes by 242 asset managers

Description as filed by funds: An advisory vote to approve the compensation of our named executive officers.

TG THERAPEUTICS INC.’s own tally for this item (“3. The advisory vote to approve the compensation of the Company's named executive officers”): 42,346,581 for, 31,019,084 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 58% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 57 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,143,6643,066,304 00Mixed
State Street1,620,5982,363 00For
TIAA01,217,287 00Against
Charles Schwab01,148,610 00Against
Fidelity128,804826,908 00Mixed
BlackRock0877,944 00Against
MUTUAL FUND SERIES TRUST0718,814 00Against
Equitable0374,322 00Against
Lincoln Financial116,00061,050 00Mixed
Direxion Shares ETF Trust0175,509 00Against
First Trust0157,249 00Against
Goldman Sachs0145,974 00Against
QUANTITATIVE MASTER SERIES LLC0127,185 00Against
SEI0110,717 00Against
ProShares0101,760 00Against
AIG/SunAmerica072,333 00Against
Global X063,047 00Against
Guggenheim060,516 00Against
John Hancock050,793 00Against
Pacific Life047,089 00Against
JPMorgan046,996 00Against
Voya045,536 00Against
MASTER INVESTMENT PORTFOLIO030,412 00Against
New York Life028,471 00Against
T. Rowe Price027,853 00Against

Fund voting reports, all 57 managers: 15,022,011 for, 9,849,970 against, 13,620 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 201 asset managers voting on “An advisory vote to approve the compensation of our named executive officers.” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street4,030,24167,165 00For
BlackRock65,9223,726,811 00Against
Wellington03,119,376 00Against
PICTET ASSET MANAGEMENT SA02,994,139 00Against
Opaleye Management Inc.00 1,830,0000Abstain
Nuveen01,225,330 00Against
Woodline Partners LP1,151,5250 00For
Charles Schwab01,148,610 00Against
Vestal Point Capital, LP0935,993 00Against
GEODE CAPITAL MANAGEMENT, LLC0885,427 00Against
683 Capital Management, LLC0785,658 00Against
Northern Trust0746,583 00Against
Hood River Capital Management LLC0615,576 00Against
Point720407,194 00Against
MELLON INVESTMENTS Corp0399,120 00Against
Vanguard395,6120 00For
JACOBS LEVY EQUITY MANAGEMENT, INC0376,682 00Against
Soleus Capital Management, L.P.360,8790 00For
Deep Track Capital, LP301,8320 00For
Duquesne Family Office LLC280,0000 00For
Sofinnova Investments, Inc.0253,478 00Against
Citadel247,9890 00For
JPMorgan0243,490 00Against
NOMURA ASSET MANAGEMENT CO LTD0230,893 00Against
Goldman Sachs793227,394 00Against

Institutional-manager reports, all 201 managers: 7,253,484 for, 21,016,875 against, 1,830,000 abstained, 29,688 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 110,028,319AGAINST: 657,578

Prior year: 99.8% for (June 14, 2023 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 57 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.

TG THERAPEUTICS INC.’s own tally for this item (“2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 110,028,319 for, 657,578 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 57 asset managers below reported 24,862,478 for, 13,620 abstained.

FOR
FOR: 24,862,478ABSTAIN: 13,620
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING” at TG THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard16,209,9680 00For
State Street1,622,9610 00For
TIAA1,217,2870 00For
Charles Schwab1,148,6100 00For
Fidelity955,7120 00For
BlackRock877,9440 00For
MUTUAL FUND SERIES TRUST718,8140 00For
Equitable374,3220 00For
Lincoln Financial177,0500 00For
Direxion Shares ETF Trust175,5090 00For
First Trust157,2490 00For
Goldman Sachs145,9740 00For
QUANTITATIVE MASTER SERIES LLC127,1850 00For
SEI110,7170 00For
ProShares101,7600 00For
AIG/SunAmerica72,3330 00For
Global X63,0470 00For
Guggenheim60,5160 00For
John Hancock50,7930 00For
Pacific Life47,0890 00For
JPMorgan46,9960 00For
Voya45,5360 00For
MASTER INVESTMENT PORTFOLIO30,4120 00For
New York Life28,4710 00For
T. Rowe Price27,8530 00For

Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).

Largest TG THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 154,565,743 shares outstanding at the time of that meeting.

Fund voting reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 10.49%
2State Street 1.05%
3TIAA 0.79%
4Charles Schwab 0.74%
5Fidelity 0.62%
6BlackRock 0.57%
7MUTUAL FUND SERIES TRUST 0.47%
8Equitable 0.24%
9Lincoln Financial 0.11%
10Direxion Shares ETF Trust 0.11%
Institutional-manager reports: top TG THERAPEUTICS INC. shareholders by shares voted on “An advisory vote to approve the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1State Street 2.65%
2BlackRock 2.45%
3Wellington 2.02%
4PICTET ASSET MANAGEMENT SA 1.94%
5Opaleye Management Inc. 1.18%
6Nuveen 0.79%
7Woodline Partners LP 0.75%
8Charles Schwab 0.74%
9Vestal Point Capital, LP 0.61%
10GEODE CAPITAL MANAGEMENT, LLC 0.57%

Reported TG THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

TG THERAPEUTICS INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock21,300,425 13.78%Form 13F, quarter ended March 31, 2024
Vanguard Group15,521,299 10.04%Form 13F, quarter ended March 31, 2024
State Street7,796,579 5.04%Form 13F, quarter ended March 31, 2024
Millennium Management3,544,046 2.29%Form 13F, quarter ended March 31, 2024
Wellington Management3,153,593 2.04%Form 13F, quarter ended March 31, 2024
Geode Capital3,107,444 2.01%Form 13F, quarter ended March 31, 2024
Citadel Advisors2,448,533 1.58%Form 13F, quarter ended March 31, 2024
Nuveen1,553,490 1.01%Form 13F, quarter ended March 31, 2024
Goldman Sachs1,519,373 0.98%Form 13F, quarter ended March 31, 2024
Northern Trust1,300,388 0.84%Form 13F, quarter ended March 31, 2024

Percentages above are of 154,565,743 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At TG THERAPEUTICS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 242 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,971 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

TG THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “TG THERAPEUTICS (TGTX) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/tg-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.